MOMA Therapeutics
PrivateLast Round
Series B
May 10, 2022
Total Funding Raised
$236M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MOMA Therapeutics is a biotechnology company that discovers and develops precision medicines by targeting molecular machines that drive human disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOMA Therapeutics Comparables
Compare MOMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Relay Therapeutics | 81% | |
| Foghorn Therapeutics | 78% | |
| Bayer AG | 77% |
MOMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 10, 2022 | ||||
| Series A | Apr 15, 2020 |
Key People
Founding team and executive leadership
MOMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| LifeSci Venture Partners | Series B |
| Creacion Ventures | Series B, Series A |
| Cormorant Asset Management | Series B, Series A |
| Goldman Sachs Asset Management Private Equity | Series B |
| Invus Opportunities | Series B |
| Alexandria Venture Investments | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 44% MoM, reaching 2.9K.
- Jun 17, 2026
Monthly visitors increased 42% MoM, reaching 2K.
MOMA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MOMA Therapeutics's valuation, stock price, and market status.
Is MOMA Therapeutics a public or private company?
MOMA Therapeutics is a private company.
What is the current stock price of MOMA Therapeutics?
MOMA Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is MOMA Therapeutics worth (valuation)?
Valuation information for MOMA Therapeutics is not publicly available.
Can I buy MOMA Therapeutics stock?
MOMA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was MOMA Therapeutics's last funding round?
MOMA Therapeutics's most recent funding round was Series B on May 10, 2022.
Who are the main investors in MOMA Therapeutics?
Key investors in MOMA Therapeutics include Goldman Sachs Asset Management Private Equity, Rock Springs Capital, Third Rock Ventures.
Will MOMA Therapeutics IPO soon?
No public IPO plans have been announced for MOMA Therapeutics.
How can I track MOMA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MOMA Therapeutics's secondary market activity and sign up for updates.